Featured Stories
DePuy ASR Hip Implants, Other Faulty Medical Devices Subject to Little FDA Oversight, Investigation Finds

DePuy ASR Hip Implants, Other Faulty Medical Devices Subject to Little FDA Oversight, Investigation Finds

A newly-published investigation from ProPublica has revealed that several questionable types of medical devices, including DePuy Orthopaedic’s recalled ASR hip implant, managed to make it to market without much scrutiny on the part of the U.S. Food & Drug Administration (FDA).

Read More

Smith & Nephew Recalls Metal-on-Metal Hip Implant Component

Smith & Nephew Recalls Metal-on-Metal Hip Implant Component

Medical device maker, Smith & Nephew, just issued a recall for a metal-on-metal hip implant component, a part of one of its all-metal hip replacement systems.

Read More

FDA Panel Takes up Metal-on-Metal Hip Implant Safety Today

FDA Panel Takes up Metal-on-Metal Hip Implant Safety Today

The Food and Drug Administration (FDA) is convening a meeting starting today to help decide the future of metal-on-metal hip implants following high-profile recalls and mounting questions about their overall safety.

Read More

Bisphosphonate Study Confirms Atypical Thigh Fracture Risk

Bisphosphonate Study Confirms Atypical Thigh Fracture Risk

New research has confirmed the link between bisphoshonates, such as Fosamax, and atypical femur fractures, a type of thigh fracture that occurs spontaneously, without any major leg injury. The study, published in the Archives of Internal Medicine, also found that the risk of atypical thigh fractures increases the longer a ...

Read More

EMA Seeks Stronger Pradaxa Guidance for Bleeding Side Effects

EMA Seeks Stronger Pradaxa Guidance for Bleeding Side Effects

Regulators in Europe have again asked Boehringer Ingelheim, the manufacturer of the blood thinner Pradaxa, to update the drug’s label with additional information regarding Pradaxa bleeding side effects. According to the European Medicines Agency (EMA), the new guidance should include more specific information on when Pradaxa must not be used, ...

Read More

First Bard Avaulta Transvaginal Mesh Lawsuit Scheduled for February Trial in MDL

First Bard Avaulta Transvaginal Mesh Lawsuit Scheduled for February Trial in MDL

The first test trials in the federal C.R. Bard Avaulta transvaginal mesh litigation will most likely start next year, according to a report from Bloomberg News. About 600 lawsuits involving Bard Avaulta transvaginal mesh products are currently pending in the multidistrict litigation underway Charleston, West Virginia. U.S. District Judge Joseph ...

Read More

FDA Metal-On-Metal Hip Replacement Investigation Is Flawed, Researchers Say

FDA Metal-On-Metal Hip Replacement Investigation Is Flawed, Researchers Say

The U.S. Food & Drug Administration’s (FDA) metal-on-metal hip replacement investigation is flawed, according to researchers.

Read More

Majority of Metal-on-Metal Hip Implant Failures Occur within Two Years, Study Finds

Majority of Metal-on-Metal Hip Implant Failures Occur within Two Years, Study Finds

A newly published metal-on-metal hip replacement study is reporting that the majority of failures occur early, within two years of surgery. The study, published in the journal Orthopedics, is just the latest to indicate that close follow-up of metal-on-metal hip implant patients is warranted.

Read More

Indiana Woman Alleges Serious Injuries From Transvaginal Mesh Products

Indiana Woman Alleges Serious Injuries From Transvaginal Mesh Products

Parker Waichman LLP, a national law firm, just filed a lawsuit on behalf of a woman who suffered injuries after receiving transvaginal mesh implants. The lawsuit suit alleges that the transvaginal mesh created an unreasonable risk and directly caused her injuries.

Read More

Pradaxa Named in Most FDA Adverse Event Reports for Deaths, Hemorrhage, Kidney Failure and Stroke

Pradaxa Named in Most FDA Adverse Event Reports for Deaths, Hemorrhage, Kidney Failure and Stroke

The controversial blood thinner, Pradaxa, surpassed all other drugs monitored by the U.S. Food & Drug Administration (FDA) in adverse event reports made to the agency last year. According to the Institute for Safe Medicine Practices’ (ISMP) latest QuarterWatch report, Pradaxa also topped the list for reports of deaths, ...

Read More

Bronchiolitis Obliterans—Popcorn Lung—Cases Continue, Lawsuits Mount

Bronchiolitis_ObliteransAccording to researchers, cases of bronchiolitis obliterans continue to be seen in a broad array of areas and involving a number of industries.

We have long followed the issue of bronchiolitis obliterans, a respiratory disease that is casually known as “Popcorn Lung.” The condition received its nickname in 2007 when it was found to be occurring in popcorn plant workers. Bronchiolitis obliterans is a potentially life-threatening, irreversible ailment, for which the only cure is a lung transplant in severe cases. Popcorn Lung inflames the bronchioles—the small lung airway—causing scarring and obliterating appropriate airflow.

The chemical flavoring diacetyl, which was popularly used in microwaveable popcorn, was long deemed the culprit in Popcorn Lung cases. The chemical is used to butter flavor a number of snack foods and also naturally occurs in some foods and drinks, according to Law360. The chemical has led to mounting lawsuits as scientists and regulators find that excessive diactyl exposure may likely lead to bronchiolitis obliterans. Continue reading

Posted in Health Concerns, Toxic Substances |

Study: Increased Diabetes Risks Seen with Some Statins

Diabetes_And_StatinsStatins, drugs prescribed to reduce blood cholesterol levels, have been associated with an increased risk for Type 2 diabetes, according to a new study.

The researchers in Canada reviewed 1.5 million people over the age of 66 in a report published in the British Medical Journal, according to BBC News Health. The study found that statins could increase risks for developing Type 2 diabetes by 22 percent when compared to less potent options. Lipitor (atorvastatin) was associated with one extra case of Type 2 diabetes for every 160 patients treated. Continue reading

Posted in Pharmaceuticals |

Thalomid Label Updated Over Serious Side Effects

Thalmoid_Label_UpdatedThalomid (thalidomide) has been associated with an increased risk of second primary malignancies, according to Celgene Inc. and Health Canada. This serious, adverse side effect has been added to the drug’s Product Monograph.

Thalomid is an immunomodulatory agent indicated for the treatment of patients who are 65 years of age or older and with a previously untreated multiple myeloma. Thalomid is prescribed in combination with melphalan and prednisone (MPT).

The Canadian Product Monograph safety information was updated to include that: Continue reading

Posted in Pharmaceuticals |

Catholic Whistleblower Group Seeks Stronger Sex Crime Policies, Legislation

Catholic_WhistleblowerMembers of the national advocacy group, Catholic Whistleblowers, comprised of Catholic clergy and nuns, is urging the Church to increase its stand against child sexual abuse.

In its first public action, Catholic Whistleblowers met in New York for a news conference, according to Milwaukee-Wisconsin Journal Sentinel (JS Online). Cardinal Timothy Dolan, head of the U.S. Conference of Catholic Bishops, and considered one of the most powerful American ecclesiastical dignitaries, is located in New York, said JS Online. Continue reading

Posted in Child Sexual Abuse, Legal News, Whistleblower |

Judge Orders DePuy Orthopaedics to Produce Compliance Reports in Pinnacle Cases

Depuy_Compliance_FilesA federal judge overseeing a multidistrict litigation against Johnson & Johnson subsidiary DePuy Orthopaedics has ordered DePuy to provide the plaintiffs with compliance reports on its metal-on-metal Pinnacle hip implant.

More than 900 individual lawsuits have been consolidated into a multidistrict litigation (MDL) in U.S. District Court for Northern Texas under Judge Ed Kinkeade, MassDevice reports. The lawsuits accuse DePuy Orthopaedics of negligence, fraud, and improper design, manufacture, and marketing of the Pinnacle system. Pinnacle hip implant recipients allege the hip’s faulty design caused problems including severe swelling, pain, bone and tissue damage, and loosening of the implant. Recipients often needed additional surgery to remove and replace the implant. Continue reading

Posted in Defective Medical Devices, Depuy |

Study: Statins May Reduce Exercise Benefits in Overweight, Obese Adults

Statins_Affect_ExcerciseA new study has found that statins, used to lower blood cholesterol levels, may reduce exercise benefits for overweight adults.

Statins rank among the best selling drugs in the world and are typically prescribed to people with obesity, diabetes, and metabolic syndrome (a combination of excess body fat and/or high blood pressure, blood sugar, and/or cholesterol), explained Medical News Today. Statins are prescribed to reduce cholesterol as a means of preventing blood clots, heart attack, and stroke that could lead to death.

Drugs in the statin class are known to carry a risk of causing myopathy (severe muscle damage) and should be taken with caution and at the lowest possible effective dose to reduce the risks of these side effects. Now, research conducted at the University of Missouri (MU) revealed that simvastatin—sold under the brand Zocor—stalled any positive effects from exercise in obese and overweight adults, according to Medical News Today. Continue reading

Posted in Crestor, Pharmaceuticals, Zocor |

Infuse® Maker, Medtronic, Cutting Staff

Infuse_Medtronic_LayoffsDevice maker, Medtronic Inc., just announced another scheduled staff cut. We recently wrote that Medtronic was laying off about 4 percent of its spinal business workforce worldwide, which amounted to about 230 of it spinal division’s 5,600 employees,

This is the third year in a row, according to Pioneer Press, that Medtronic has announced cuts. The announcement was made during a conference call and confirmed that the device maker plans on eliminating 2,000 jobs worldwide. About half will impact Medtronic’s workforce in the United States, according to the firm’s chief financial officer, Gary Ellis. Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Defibrillators, Medtronic Infuse |

da Vinci Robotic Surgery Case With Jury

da_Vinci_Jury_TrialJury deliberations are scheduled in the first of some 26 lawsuits brought over Intuitive’s da Vinci robotic surgical system and involve allegations of injuries associated with the controversial robotic system.

Kitsap County Superior Court Judge Jay Roof (Port Orchard, Washington), just handed the case to the 12-member jury after a five-week trial, according to Bloomberg News. Deliberations being this week.

Personal injury lawsuits have alleged that the da Vinci system has caused patients to suffer from a variety of adverse events, including internal injuries. Many of these injuries are the result of burns, tears, and other complications. In some cases, patients have died or suffer from chronic pain, even disability. da Vinci lawsuits fault aggressive Intuitive marketing positioned to induce hospitals to buy the costly system. Lawsuits also allege that a collaboration of design flaws and poor physician training on the da Vinci led to the injuries alleged in the litigation. At last count, some 70 deaths have been tied to the system since 2009. Continue reading

Posted in da Vinci Surgical Robot, Defective Medical Devices |

Jurors Told Intuitive Surgical Ran Like a Car Dealership

Intuitive-Surgical-Car-DealershipIn a case involving the safety of Intuitive Surgical’s da Vinci robotic system, the jury was told that the company acted “just like a car dealership” in training doctors to use the equipment.

In addition, jurors heard that the plaintiff, Fred Taylor, had died because of the company’s practices, and that Intuitive should pay more than $8 million in damages to his estate. These remarks were part of the plaintiff’s attorney’s closing arguments in a Port Orchard, Washington state court, Bloomberg News reports.   Continue reading

Posted in da Vinci Surgical Robot, Defective Medical Devices |

End in Sight for Water-Contamination Cleanup at Camp Lejeune

Camp_Lejeune_Water_ContaminationAt Camp Lejeune, the North Carolina Marine Corps base, cleanup continues of the decades-long drinking-water contamination problem that began in the 1950s.

More than 600 polluted sites are scattered around the 170-square-mile Marine base, located at the mouth of the New River. About five-dozen sites remain to be cleaned up, according to The Associated Press (AP). The contamination comes from a variety of pollutants – leaking gasoline from the base’s fuel storage farm, and chemicals including carcinogenic pesticides, benzene, and dry-cleaning solvents, some of which were intentionally dumped at Lejeune. Continue reading

Posted in Benzene, Camp Lejeune Toxic Water, Health Concerns, Toxic Substances |